New Haven, Conn. — Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians are presenting research studies at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) June 3-7 in Chicago, IL. This year’s scientific program will feature more than 2,800 abstracts in over 120 subcategories.
At this year’s meeting, the latest cancer research findings from Yale Cancer Center and Smilow Cancer Hospital will show new treatments and diagnostic advances in head and neck, gynecological, lung, prostate, and gastric cancers, melanoma, and many other areas of oncology. Some of the research highlights include:
Presenter: Pamela L. Kunz, MD, Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and YaleCancer Center; Associate Professor of Medicine (Medical Oncology)
Presenter: Lajos Pusztai, MD, DPhil, Professor of Medicine (Medical Oncology), Yale Cancer Center
Presenter: Tara Sanft, MD, Associate Professor of Medicine (Medical Oncology), Yale Cancer Center, Chief Patient Experience Officer and Director of Survivorship, Smilow Cancer Hospital
Overall survival from a phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non–small cell lung cancer previously treated with immunotherapy: Lung-MAP nonmatched substudy S1800A
Senior Author: Roy S. Herbst, MD, PhD, Deputy Director for Clinical Affairs and Chief Medical Officer, Yale Cancer Center and Smilow Cancer Hospital
Presenter: Harriet Kluger, MD, Professor of Medicine (Medical Oncology), Clinical Program Leader, Melanoma, YaleCancer Center and Smilow Cancer Hospital
Senior Author: Maryam Lustberg, MD, MPH, Associate Professor of Medicine (Medical Oncology) and Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center
A full list of Yale Cancer Center participation at ASCO and schedule of events can be found online.
# # #